Benefits of and Barriers to Pharmacogenomics-Guided Treatment for Major Depressive Disorder
Author:
Affiliation:
1. Department of Psychiatry and Psychology and Mayo Clinic Depression Center; Rochester Minnesota USA
2. Division of Clinical Pharmacology, Department of Molecular Pharmacology & Experimental Therapeutics; Mayo Clinic; Rochester Minnesota USA
Funder
Mayo Clinic
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Reference5 articles.
1. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice;Trivedi;Am. J. Psychiatry,2006
2. Pharmacogenomics: precision medicine and drug response;Weinshilboum;Mayo Clin. Proc.,2017
3. TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics;Gupta;Mol. Psychiatry,2016
4. Preemptive pharmacogenomic testing for precision medicine: a comprehensive analysis of five actionable pharmacogenomic genes using next-generation DNA sequencing and a customized CYP2D6 genotyping cascade;Ji;J. Mol. Diagn.,2016
5. Integrating pharmacogenomics into clinical practice: promise vs reality;St Sauver;Am. J. Med.,2016
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efficacy and safety of pharmacogenomic-guided antidepressant prescribing in patients with depression: an umbrella review and updated meta-analysis;Frontiers in Psychiatry;2024-07-11
2. Genophenotypic Factors and Pharmacogenomics in Adverse Drug Reactions;International Journal of Molecular Sciences;2021-12-10
3. Potential pharmacogenomic targets in bipolar disorder: considerations for current testing and the development of decision support tools to individualize treatment selection;International Journal of Bipolar Disorders;2020-07-04
4. Opportunities and challenges of implementation models of pharmacogenomics in clinical practice;Personalized Psychiatry;2020
5. Pharmacogenomics of treatment response in major depressive disorder;Personalized Psychiatry;2020
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3